The flow cytometry-based assay measures the expression of the protein FcyR11a as a biomarker for cardiovascular risk.
Chancellor tells the City she is “clear that the financial services sector must play a central part in our economic vision ...
The FDA has granted a de novo clearance to a wearable device—with a form factor you’re familiar with—that can check patients ...
Primary care clinicians and practices are uniquely positioned to help people achieve optimal cardiovascular health through screening, diagnosing and treating the health behaviors and factors outlined ...
The music documentary Takin’ Care of Business took care of business at the inaugural Round Top Film Festival in Texas. The ...
This is the shocking moment a cargo plane crashed into a radio antenna after overshooting an airport runway in Colombia. The Aerosucre aircraft bound for Valencia, Spain was taking off from the El ...
CardiAMP ® autologous cell therapy in ischemic heart failure of reduced ejection fraction (BCDA-01) The FDA accepted our plans for completing patient follow-up in the CardiAMP Heart Failure Trial this ...
Boost, GPx will refine the accuracy of its debut product, CardioID, the world’s first implant and needle-free remote blood monitoring solution for heart failure patients ... McKinsey & Company, Sony ...
The growing prevalence of cardiovascular and thrombotic disorders is driving strong demand for D-dimer testing. As blood clot-related risk factors continue to increase, the need for precise ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback